Synergy of Centralized Drug Volume-based Purchasing and Medical Insurance Negotiation Policy
- VernacularTitle:药品集中带量采购与医保谈判政策的协同作用
- Author:
Qingli TAN
1
,
2
;
Runyi GUO
1
;
Huilin SUN
3
;
Dachuan YU
4
Author Information
1. School of Medical Business，Guangdong Pharmaceutical University，Guangdong Zhongshan 528400，China
2. Guangdong Research Base for Drug Regulatory Science，Guangzhou 510006，China
3. Dept. of Endocrinology，the First Affiliated Hospital of Guangdong Pharmaceutical University，Guangzhou 510080，China
4. Institute of Social Security，Guangdong University of Finance，Guangzhou 510521，China
- Publication Type:Journal Article
- Keywords:
Centralized drug volume-based purchasing;
Medical insurance negotiation;
Synergy;
Medical reform
- From:
China Pharmacy
2021;32(15):1793-1799
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE：To investigate the s ynergy between centralized drug volume-based purchasing （called“volume- based purchasing”for short ）and medical insurance negotiation policy. METHODS ：From the aspects of economic and social benefits ， the synergy of volume-based purchasing and medical insurance negotiation was analyzed by using the methods of literature analysis，policy interpretation and interview. The corresponding suggestions were put forward for the problems of the supply and use of drugs. RESULTS & CONCLUSIONS ：The synergy of volume-based purchasing and medical insurance negotiation in terms of economic benefits include medical insurance fund management optimization to improve fund utilization efficiency improvement ； medical insurance fund payment optimization to reduce transaction cost ；network promotion of medical security information platform to reduce the cost of information exchange. The synergy of volume-based purchasing and medical insurance negotiation in terms of social benefits includes relevant index assessment of drug quality evaluation to improve drug quality evaluation system ； medical service level improvement to form compound medical insurance payment mode under total budget management ；enterprise supervision driven by market to reduce the pressure of government supervision. The relevant departments should continue to strengthen the comprehensive management of medical institutions to reduce the phenomenon of irrational drug use ；strengthen policy convergence ，avoid the poor implementation of medical insurance drug adjustment policy ，so that the policy dividend of volume-based purchasing and medical insurance negotiation can benefit the people more through system reform ，optimal allocation of funds ，etc.
